Efficacy of monotherapy with 15 antihypertensive agents in treating essential hypertension assessed by 24-hour ambulatory blood pressure monitoring

Acta Academiae Medicinae Sinicae

Volumn 29, Issue 6, 2007, Pages 792-796

  Hua, Cong Xiao ^a   Hua, Lu ^a   Li, Na ^a   Wang, Li ^a   Pang, Hui Min ^a   Ming, Guang Hua ^a   Huang, Yan ^a   Cheng, Xiao Ru ^a   Liu, Hong ^a   Wu, Ying ^a   Xu, Li ^a   Kang, Jian ^a   Xu, Zhi Min ^a   Li, Yi Shi ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

Ambulatory blood pressure monitoring; Essential hypertension; Monotherapy

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENAZEPRIL; BENIDIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEVANTOLOL; CALCIUM ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; INDAPAMIDE; IRBESARTAN; LONG ACTING DRUG; LOSARTAN; METOPROLOL; OLMESARTAN; TERAZOSIN; TORASEMIDE; VALSARTAN;

ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG DOSE REGIMEN; DRUG EFFICACY; ESSENTIAL HYPERTENSION; HEART RATE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MONOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; DOXAZOSIN; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; PRAZOSIN; RECEPTORS, ANGIOTENSIN; SULFONAMIDES; TREATMENT OUTCOME;

EID: 38849199206     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Chinese source.
2. Chinese source.
3. Chinese source.
4. Chinese source.
5. Chinese source.
6. Chinese source.
7. Fairhurst GJ. Comparison of bevantolol and atenolol for systemic hypertension [J]. Am J Cardiol, 1986, 58(12): 25E-27E.
8. Mallion JM, Asmar R, Boutelant S, et al. Twenty-four hour antihypertensive efficacy of indapamide, 1.5-mg sustained release: results of two randomized double-blind controlled studies [J]. J Cardiovasc Pharmacol, 1998, 32(4):673-678.
9. Reyes AJ. Diuretics in the therapy of hypertension [J]. J Hum Hypertens, 2002, 16(Suppl 1):S78-S83.
10. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [J]. Hypertension, 2003, 42(3):239-246.
11. Chinese source.
12. Manos J. A long-term study of doxazosin in the treatment of mild or moderate essential hypertension in general medical practice [J]. Am Heart J, 1991, 121(1 pt 2):346-351.
13. Beitelshees AL, Zineh I, Yarandi HN, et al. Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertension [J]. Pharmacotherapy, 2006, 26(9):1247-1254.
14. Chern CM, Hsu HY, Hu HH, et al. Effects of atenolol and losartan on baroreflex sensitivity and heart rate variability in uncomplicated essential hypertension [J]. J Cardiovasc Pharmacol, 2006, 47(2):169-174.
15. Chinese source.